Delivery Order SPE2DB20D1004-SPE2DB24FNCRF

Award Date 9/20/24
Potential Completion Date 9/23/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Isentress 400 mg tablets to the Defense Logistics Agency (DLA). The $4,227.79 firm fixed-price delivery order has an ultimate completion date of August 2, 2024. This is not a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999, which enables the agency to efficiently procure a comprehensive...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,236.60 firm fixed-price delivery order covers the procurement of Isentress 400mg tablets, with an ultimate completion date of May 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,463.27, is for the delivery of Isentress 400 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of May 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,218.31, is for the delivery of Isentress 400 mg tablets to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,239.02, is a Firm Fixed Price Delivery Order for the drug Isentress 400 mg Tablet 60s. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,296.18 Firm Fixed Price delivery order is for ISENTRESS 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,185.24 firm-fixed-price delivery order is for the supply of Isentress 400 mg tablets, a prescription medication. The contract has an ultimate completion date of August 23, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999, which enables the DLA to efficiently procure...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $4,740.96 firm fixed-price delivery order is for the supply of Isentress 400 mg tablets, a prescription medication used to treat HIV infection. The contract has an ultimate completion date of June 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,188.14 Firm Fixed Price delivery order is for the supply of ISENTRESS 400 mg tablets, a pharmaceutical product. The contract has a completion date of July 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Isentress 400 mg tablets. The $1,268.94 firm fixed-price contract has an ultimate completion date of April 16, 2025 and is not set aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FNCRF
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Isentress 400 mg tablets. The contract, valued at $1,185.24, is a delivery order with a firm fixed price and an ultimate completion date of September 23, 2024. The contract is not designated with a set-aside requirement, indicating open competition.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 2/27/25, 9:58 AM